Safety, efficacy and pharmacokinetics of humanized anti-CD52 monoclonal antibody alemtuzumab in Japanese patients with relapsed or refractory B-cell chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Safety, efficacy and pharmacokinetics of humanized anti-CD52 monoclonal antibody alemtuzumab in Japanese patients with relapsed or refractory B-cell chronic lymphocytic leukemia

Published:2017-01-01 Issue:1 Volume:47 Page:54-60
ISSN:0368-2811
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Ishizawa Kenichi¹,Fukuhara Noriko¹,Nakaseko Chiaki²,Chiba Shigeru³,Ogura Michinori⁴,Okamoto Akihiko⁵,Sunaga Yoshinori⁵,Tobinai Kensei⁶

Affiliation:

1. Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Miyagi

2. Department of Hematology, Chiba University Graduate School of Medicine, Chiba

3. Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki

4. Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Nagoya, Aichi

5. Sanofi K.K., Shinjuku-ku, Tokyo

6. Department of Hematology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/47/1/54/26567510/hyw146.pdf

Reference19 articles.

1. Chronic lymphocytic leukemia;Rozman;N Engl J Med,1995

2. Chronic lymphocytic leukemia: an updated review;Faguet;J Clin Oncol,1994

3. Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan;Tamura;Eur J Haematol,2001

4. Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia;Sawitsky;Blood,1977

5. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia;Rai;N Engl J Med,2000

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-Induced Myelosuppression in Kidney Transplant Patients;Experimental and Clinical Transplantation;2021-10

2. CD52-targeted depletion by Alemtuzumab ameliorates allergic airway hyperreactivity and lung inflammation;Mucosal Immunology;2021-03-17

3. Safety of Newer Disease Modifying Therapies in Multiple Sclerosis;Vaccines;2020-12-26

4. Targeting phosphatidylserine for Cancer therapy: prospects and challenges;Theranostics;2020

5. Impact of alemtuzumab pharmacokinetics on T-cell dynamics, graft-versus-host disease and viral reactivation in patients receiving allogeneic stem cell transplantation with an alemtuzumab-based T-cell-depleted graft;Transplant Immunology;2019-12